TrialFrontiers in immunology2026

Sequential versus concurrent neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma: a randomized, controlled, open-label, phase 2 trial (HCHTOG1906).

Yan Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.